Year To Quarter End Statement Of Income

Oncolys BioPharma Inc. - Filing #7727011

Concept 2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
Year to quarter end statement of income
Statement of income
Net sales
120,000 JPY
JPY
33,874,000 JPY
33,874,000 JPY
33,754,000 JPY
JPY
15,380,000 JPY
15,380,000 JPY
15,380,000 JPY
JPY
Cost of sales
28,523,000 JPY
JPY
Gross profit (loss)
5,350,000 JPY
15,380,000 JPY
Selling, general and administrative expenses
308,015,000 JPY
250,495,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-29,577,000 JPY
-146,400,000 JPY
-156,263,000 JPY
-302,664,000 JPY
-126,686,000 JPY
-121,013,000 JPY
-235,115,000 JPY
-23,299,000 JPY
-114,101,000 JPY
-90,802,000 JPY
Non-operating income
Interest income
3,220,000 JPY
1,049,000 JPY
Non-operating income
3,251,000 JPY
1,078,000 JPY
Non-operating expenses
Interest expenses
762,000 JPY
695,000 JPY
Non-operating expenses
11,026,000 JPY
7,541,000 JPY
Ordinary profit (loss)
-310,439,000 JPY
-241,578,000 JPY
Profit (loss) before income taxes
-310,439,000 JPY
-241,578,000 JPY
Income taxes - current
946,000 JPY
969,000 JPY
Income taxes
946,000 JPY
969,000 JPY
Profit (loss)
-311,386,000 JPY
-242,547,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.